Recent

% | $
Quotes you view appear here for quick access.

Simulations Plus, Inc. Message Board

  • dickmilde dickmilde Jul 27, 2014 10:49 AM Flag

    Taglich has an updated research report on SLP

    Maintaining Speculative Buy rating. Our rating is
    based on new contracts with two top-five pharmaceutical
    companies, expanded simulation software sales to
    consumer product companies (that manufacture products
    such as detergent, makeup, toothpaste, etc.) that need
    toxicology capability, the launch of MembranePlus
    software in August 2014, modest price increases
    beginning in the 2H14, and a March 2014 distributor
    agreement signed with the Research Institute for Liver
    Diseases in Shanghai, China.
    We forecast income growth accelerating from 5.7% in FY14 to 32.8% in FY15

 
SLP
6.67+0.17(+2.62%)Aug 28 4:00 PMEDT